Google (GOOG) shareholders are celebrating today on news that the verdict is in on Oracle's (ORCL) patent attack and that they were found not to be infringing.But this does not end the matter. Judge William Alsup still has to rule on the copyright portion of the case.And this could be troubling, for both Google and open source in general.The judge has taken the copyright portion of the complaint under advisement, and is expected to rule on that next week. While it's possible he could rule that Google's use of Oracle's Java headers constituted "fair use," that such use was necessary for Google's Dalvik virtual machine to meet the promises Sun had made for the software when it was first written - write it once, run ... Continue reading →
PALO ALTO, CA--(Marketwire -05/23/12)- HP (HPQ) today outlined plans for a multi-year productivity initiative designed to simplify business processes, advance innovation and deliver better results for customers, employees and shareholders. The restructuring is expected to generate annualized savings in the range of $3.0 to $3.5 billion exiting fiscal year 2014, of which the majority will be reinvested back into the company. Enabling investments in people, processes and technology will allow HP to accomplish the restructuring effort and to generate the savings. These moves are expected to yield significant improvements in efficiency and customer service during the next several years. HP expects to use the savings to boost investment in innovation around its three areas of strategic focus: cloud, big data and security, as well as ... Continue reading →
5/17/2012 7:21 AM ET (RTTNews) - Rosetta Genomics Ltd. (ROSG: News ) announced Wednesday morning that Novitas informed the company that it plans to cover the company's miRview mets² assay for all Medicare beneficiaries. MiRview mets² accurately identifies the primary tumor of origin in primary and metastatic cancer.Rosetta Genomics gapped up Wednesday and rose steadily throughout the first hour of trade. The stock finished up by 3.37 at $4.99 on the highest volume of the year and broke out to over a one-month high. Click here to receive FREE breaking news email alerts for Rosetta Genomics Ltd. and others in your portfolioby RTT Staff WriterFor comments and feedback: contact editorial@rttnews.com Continue reading →
Everyone hates Europe, right? If it's Europe, sell it. Stay away.Not exactly. Some Europeans are winning. One European technology firm, in particular, is winningSAP (SAP).SAP and Oracle (ORCL) have been rivals for years. Oracle CEO Larry Ellison became a legend by putting nearly all such rivals down for the count. He bought potential competitors and dominated enterprise software.That may no longer be the case. The reason is SAP.As business has moved to the cloud, SAP and Oracle have both been threatened. But it's increasingly obvious that Oracle's strategy, buying hardware maker Sun Microsystems, was a huge blunder, while SAP's strategy of buying cloud software companies and offering services around it makes sense.The latest evidence is SAP's purchase of Ariba for $4.3 billion.Ariba arrived in the ... Continue reading →